Background. Accurate numbers of copies of Kaposi sarcoma-associated herpesvirus (KSHV) and numbers of virus-infected cells in lesions caused by KSHV-associated diseases are unknown.
of infection: lytic and latent [1, 12] . During the lytic phase, KSHV replicates in infected cells, which results in cell lysis. However, the virus does not replicate in latently infected cells, although they harbor viral episomes and express several KSHV-encoded latency-associated proteins, such as latency-associated nuclear antigen (LANA) and LANA2 [1, 13, 14] . Although latent infection predominates in KSHV-infected PEL cell lines, phorbol ester stimulation can induce lytic infection in these cells [12] . Gene expression during the lytic phase is classified into immediate early, early, and late expression [12] . Open-reading frame (ORF)-50 was identified as an immediate early protein that was required for the lytic replication of KSHV [12, 15, 16] . Immunohistochemical studies demonstrated that KS cells expressed LANA; however, the expression of lytic proteins was very rare in KS lesions, which suggests that latent infection predominates in KS cells [5, 6, 17] . Lytic proteins are expressed by some B cells in the mantle zone of MCD, which suggests that lytic replication frequently occurs in MCD lesions [6, 17] .
Numbers of KSHV copies in KSHV-associated diseases have been investigated by several groups [18] [19] [20] [21] [22] [23] [24] [25] [26] . An early study that used conventional PCR and South- ern blot analysis demonstrated that a PEL cell contained ∼50 copies of KSHV genome, whereas the KSHV genome was detected at a rate of ∼1 viral copy/cell in KS lesions [18] . Recently, real-time PCR was used to detect KSHV, and several reports have described numbers of viral copies in peripheral blood mononuclear cells (PBMCs) derived from patients with KS [19] [20] [21] [22] [23] [24] [25] [26] . Studies using real-time PCR have demonstrated that numbers of viral copies in PBMCs varied among diseases and disease stages [21] [22] [23] [24] . However, to our knowledge, there has been no report that has compared numbers of viral copies in KS, PEL, or MCD lesions using real-time PCR. Therefore, the aim of the present study was to determine numbers of viral copies in lesions of KSHV-associated diseases using pathologic samples. Pathologic tissue samples-such as biopsy samples-frequently contain both virus-infected cells and noninfected cells. Thus, results from real-time PCR do not solely represent numbers of viral copies in virus-infected cells. To solve this problem, we combined real-time PCR with computerized-image analysis that allowed an assessment of numbers of virus-infected cells in immunostained sections. Using these methods, we identified numbers of both viral copies and virus-infected cells in appropriate sections. Thus, we obtained relatively accurate numbers of viral copies in histologic sections of KSHV-associated disease lesions.
PATIENTS, MATERIALS, AND METHODS

Patients and samples.
All patients provided informed consent for specimens to be obtained. For PCR analysis, 21 clinical samples were collected (table 1) . For immunohistochemical analysis, 27 histopathologic specimens from KSHV-infected patients (table 2) were collected from 1995 to 2004. All KS specimens were categorized into groups according to the clinical stage of KS (patch, plaque, or nodular) on the basis of clinical and histologic data. DNA extracted from 2 KSHV-positive cell lines (BCBL-1 and TY-1), a KSHV-negative Epstein-Barr viruspositive Burkitt lymphoma cell line (Raji), and human umbilical vascular endothelial cells (HUVECs) was used as a control for PCR studies [27, 28] . Preparation of DNA. DNA was extracted from fresh-frozen clinical materials or from formalin-fixed, paraffin-embedded tissue samples from 21 biopsies of KSHV-infected patients (table 1) . For fresh-frozen materials, the DNeasy Tissue Kit (Qiagen) was used in accordance with the manufacturer's instructions. For the isolation of DNA from formalin-fixed, paraffin-embedded biopsy samples, 5-mm sections ( ) were n p 3-4 deparaffinized with xylene, digested with proteinase K, and processed for phenol/chloroform extraction with sodium acetate/ethanol precipitation. Real-time quantitative PCR. Amounts of KSHV DNA were determined by quantitative real-time (TaqMan) PCR using the ABI Prism 7900HT sequence detection system (Applied Biosystems), which amplified segments within the KSHV LANA gene (one of the latent proteins coded on ORF73). Sequences and usage parameters of primers and probes have been described elsewhere [19] . We also determined the amounts of human genomic DNA that were present in DNA extracted from each specimen. Primers and probes for the gene encoding human glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were designed, using Primer Express software (Applied Biosystems), to obtain a 104-bp amplicon. Forward and reverse primer sequences were 5 -GCTCCCTCTTTCTTTGCAGCAAT-3 and 5 -TACCATGAGTCCTTCCACGATAC-3 , respectively. The fluorogenic TaqMan probe was 5 -(FAM)TCCTGCACCACCAAC-TGCTTAGCACC(TAMRA)-3 . PCR amplification was performed in 25-mL reaction mixtures using QuantiTect probe PCR Master Mix (Qiagen), 0.4 mmol/L each primer, 0.2 mmol/L TaqMan probe, and 2 mL of isolated DNA. PCR conditions were 15 min at 95ЊC, followed by 45 cycles of 15 s at 94ЊC and 1 min at 60ЊC. Quantitative results were obtained by generating standard curves for pGEM-T plasmids (Promega) that contained each KSHV (ORF73) and cellular target (GAPDH) amplicon. The number of viral copies per cell was calculated by dividing the number of ORF73 copies by one-half of the number of GAPDH copies, because there are 2 alleles of GAPDH in each cell.
Detection of KSHV by semiquantitative PCR-Southern blotting analysis. Semiquantitative PCR-Southern blotting was performed to determine copy numbers of KSHV in DNA samples after PCR amplification of KS330 233 [11, 29] . The bglobin gene was simultaneously amplified as described elsewhere [11] . For PCR-Southern blot analysis, digoxygenin (DIG)-labeled KS330 233 and a 110-bp DNA fragment of the b-globin gene, whose sequences were confirmed by sequencing, were used as probes [11] . Procedures for Southern blot analysis and the detection of DIG were those of the manufacturer (Roche Diagnostic). Copy numbers of KSHV were determined by comparing results for KS330 233 and b-globin, on the basis of the information that each cell has 2 copies of the b-globin genome.
Histologic and immunohistochemical analyses. Serial sections were prepared and stained with hematoxylin-eosin (HE) for light microscopy or were subjected to immunohistochemical staining with antiserum against LANA or ORF50 proteins (lytic antigens) [4, 30] . Immunohistochemical staining was visualized using the avidin-streptavidin-peroxidase method with 3-3 diaminobenzidine as the chromogen, as described elsewhere [4, 30] . For double immunohistochemical staining of vascular endothelial cell growth factor receptor-3 (VEGFR-3) and LANA, an anti-LANA rabbit polyclonal antibody, a peroxidase-conjugated anti-rabbit goat antibody (Envision; Dako Cytomation), and aminoethylcarbazole (AEC; Nichirei) were used as the primary antibody, secondary antibody, and chromogen, respectively. After the color development of AEC, slides were washed with PBS and processed for VEGFR-3 staining. Anti-VEGFR-3 mouse monoclonal antibody (D2-40; Nichirei) and alkaline phosphatase-conjugated anti-mouse IgG goat antibody (Envision; Dako Cytomation) were used, and a positive signal was detected with Fast Blue BB (Sigma-Aldrich). Slides were mounted with a glycerol-based mounting solution. Computerized-image analysis for KSHV-positive cells. To estimate numbers of KSHV-infected cells in lesions of KSHVassociated diseases, computerized analysis of immunohistochemical images was performed using ImageJ software (version 1.33u; National Institutes of Health). A representative image of each section from each sample was captured at ϫ40 or ϫ100 magnification. First, the image was split into red, green, and blue colors; then the 3 images were converted to gray-scale images. The total number of cells was counted in the red image, and the number of KSHV-infected cells (stained by the antiserum against KSHV proteins) was counted in the blue image. A threshold was set, for clear visualization of the displayed image. For counting cells, "analyze particle" was selected from "analyze" in the menu bar, and the minimum size was set at 30. After the accuracy of cell outlines generated by the software was verified, numbers of cells were calculated in separate windows.
RESULTS
Amount of KSHV viral genome in KSHV-associated lesions.
To determine the relationships between amounts of KSHV genome and KSHV-associated diseases, we performed real-time PCR to detect KSHV ORF73 and GAPDH in appropriate DNA samples. Specificity of the assay for ORF73 was confirmed using a panel of DNA from other herpesviruses (HHV-1-7) and cellular DNA from HUVECs and Raji cells (data not shown). The assay for ORF73 uniformly detected 10 copies of pGEM-ORF73 plasmid ( figure 1A and 1C) . PCR amplification of GAPDH also uniformly detected 10 copies of GAPDH genome (figure 1B and 1C). Amplification plots and standard curves demonstrated a linear relationship between numbers of copies from 10 to 10 8 and the cycle threshold, which indicates that dynamic ranges of these 2 real-time PCRs were between 10 and 10 8 copies. To validate differences between DNA samples from frozen tissues and those from paraffin-embedded tissues, we tested a DNA sample from a frozen cell pellet of TY-1 and a DNA sample from a paraffin-embedded TY-1 cell pellet. No significant difference was detected between these 2 types of DNA (data not shown).
Results of real-time PCR showed signs of a positive association between the number of viral copies per cell and disease (table 1 and figure 1D ). A DNA sample from PEL demonstrated a number of KSHV copies similar to that of PEL cell lines (PEL, 82; PEL cell lines, 87). DNA from samples of KSHV-associated solid lymphoma also showed a high number of KSHV copies (average, 10.8 viral copies/cell). DNA from samples of KS and MCD demonstrated lower numbers of viral copies than those of KSHV-associated lymphoma (PEL and KSHV-associated solid lymphoma). The average number of KSHV copies in DNA from KS samples was 1.58 viral copies/cell (range, 0.00-5.50 viral copies/cell), whereas those in DNA samples from the nodular and patch/plaque stages of AIDS-associated KS samples were 1.72 and 0.13 viral copies/cell, respectively. DNA samples from classic KS (KS in patients without HIV infection) also had !5 viral copies/cell. A DNA sample from an MCD lesion had 0.27 viral copies/cell. To confirm these results, we performed semiquantitative PCR-Southern blot analysis using some of these samples. Results demonstrated similar copy numbers resulting from the 2 techniques (table 1 and figure 2) . Thus, quantitative PCR analysis suggested that PEL might have the highest copy number (82 copies), followed by KSHV-associated solid lymphoma (11 copies). KS and MCD lesions contained lower copy numbers (∼1 copy/cell), regardless of HIV-infection.
Number of KSHV-infected cells in KSHV-associated diseases. Because pathologic tissue samples present cells contaminated in varying degrees, all DNA samples that we used for real-time PCR actually contained DNA extracted from histologically normal cells and noninfected (LANA-negative) cells, as confirmed by histologic data. To determine accurate KSHV copy numbers in a KSHV-infected cell in a lesion, knowledge is required of accurate numbers of KSHV-infected cells in a specific sample. Thus, we performed computerized-image analysis of immunostained sections to estimate the number of KSHV-positive cells. Because it is recognized that all KSHV-infected cells express LANA in the nuclei, we counted cells expressing LANA in the nuclei as KSHV-infected cells. LANA was stained brown in immunohistochemical analysis, and cell nuclei were counterstained with hematoxylin (violet). Therefore, brown nuclei were counted as LANA-positive cells, and violet entities were counted as nuclei by the image-analysis software ImageJ ( figure  3) . Results revealed that 80% of cells in tissue samples from KSHV-associated solid lymphoma were LANA positive (table 2 and figure 3L ). Tissues obtained from AIDS-associated and non-AIDS-associated KS contained 12%-95% (average, 49%) LANA-positive cells. The MCD sample contained 8% (range, . of viral copies and percentage of latency-associated nuclear antigen (LANA-) or open-reading frame (ORF)-50- figure 2 ). The number of KSHV copies was significantly lower in patch/ plaque-stage lesions (range, 0.04-0.30 viral copies/cell; average, 0.13 viral copies/cell) than in nodular-stage lesions (range, 0.10-3.90 viral copies/cell; average, 1.72 viral copies/cell) (P ! , Mann-Whitney U test). In contrast, the number of KSHV .05 copies was similar in both patch/plaque-and nodular-stage lesions in classic KS. Computerized-image analysis of immunohistochemically stained sections revealed that LANA-positive cell populations in the nodular stage (57%) were larger than those in the patch/plaque stage (48%); however, there was no significant difference between them. Lytic ORF50 protein-positive cells were very rare (0%) in both stages (figure 3L and 3M and table 3), which implies that lesions in KS were mainly composed of proliferating KSHV latently infected cells. Differences in numbers of viral copies between the 2 stages in AIDSassociated KS may simply be related to the numbers of latently infected cells.
KSHV-positive cells during the early stage of KS. According to the results of quantitative PCR, relatively high numbers of KSHV copies were detected in patch-stage KS tissue samples ( figure 1D ). In addition, KSHV-positive cells were detected at a rate of ∼50% even during the early stage of KS, although numbers of viral copies in DNA from patch-stage samples were lower than those in nodular-stage samples. To clarify why such a high number of viral copies was present during the patch stage of KS, we investigated the localization of KSHV-positive cells in histologically stained sections at the patch stage. Histologic analysis showed an abnormal enlargement of blood capillaries with extended endothelial cells during the patch stage ( figure 4A ). Spindle cells were also sometimes observed around vessels at this stage. Many previous research groups have reported that these spindle-shaped cells were positive for KSHV; however, there has been no report that has described the KSHV status of these extended endothelial cells in enlarged capillaries during the early stage of KS. Here, double labeling revealed that both enlarged endothelial cells and spindle cells around capillaries were positive for LANA and VEGFR-3 (figure 4A and 4B). VEGFR-3 is a marker of lymphatic endothelial cells, and it is known that KSHV infection alters the gene profile and induces the expression of VEGFR-3 in endothelial cells [31] [32] [33] . All KS spindle cells at every stage expressed both LANA and VEGFR-3 ( figure 4A-4F) . No signal for LANA or VEGFR-3 was found in normal endothelial cells from capillaries or blood vessels in KS lesions ( figure 4C and 4D ). These data suggest that KSHV may infect endothelial cells at a very early stage in KS lesions and that infection may induce an abnormal extension of endothelial cells and an enlargement of blood vessels, resulting in a relatively high number of KSHV copies.
DISCUSSION
In the present study, we evaluated numbers of viral copies and numbers of KSHV-infected cells in KSHV-associated diseases using real-time quantitative PCR and a computerized-image analytical method. The predicted number of KSHV copies was 3.2 viral copies/cell. The expression of ORF50 protein was rare or nonexistent in KS lesions, which suggests that latently infected cells were proliferating in KS lesions. In MCD samples, 25% of KSHV-infected cells expressed ORF50 protein, which implies that the lytic replication of KSHV was frequent in MCD lesions. To our knowledge, this is the first study describing both numbers of viral copies and numbers of virus-infected cells in pathologic samples from KSHV-associated disease lesions.
The combination of real-time PCR and computerized-image analysis allowed the prediction of numbers of viral copies per infected cell in each KSHV-associated disease. Predicted copy numbers per infected cell are listed in table 3. KS lesions might contain 0.27-5.89 viral copies/cell (average, 3.22 viral copies/ cell) of KSHV. KSHV-associated solid lymphoma cells might contain 110 viral copies/cell. These numbers were close to the ones reported for KS cells (1 viral copy/cell) and PEL cells (50 viral copies/cell) [18, 19] . Because almost all KS cells express LANA, a KS cell should have 11 copy of the virus. One molecule of LANA binds to 1 copy of the KSHV genome on chromosomes of host cells [34] . Immunohistochemical staining produces several dots of LANA in the nucleus of every KS cell [4, 6] . Thus, it is not surprising that a KS cell has several copies of KSHV. Like KS cells, PEL and KSHV-associated solid lymphoma cells exhibited several dots of LANA staining in their nucleus by immunohistochemical analysis, which suggests that PEL and KSHV-associated solid lymphoma cells also have several copies per cell. However, numbers of viral copies in PEL and KSHV-associated solid lymphoma cells were obviously higher than those in KS cells. One reason for that was that 3% of KSHV-associated solid lymphoma cells expressed ORF50 protein, which implies that a small population of lymphoma cells was in the lytic phase, whereas cells expressing ORF50 protein were very rare (!0.1%) in KS cells (table 3) . These data suggest that there might be different systems involved in the maintenance or replication of viruses between KSHV-infected lymphoma cells and KS cells. KSHV-positive cells contained 3.38 viral copies/cell in MCD. This number seemed to be lower than what we expected, given that one-fourth of KSHV-infected cells expressed ORF50 protein. We could not determine numbers of viral copies in MCD, because numbers of viral copies might vary among cases, and we examined the virus titer in only one MCD sample. Further studies are definitely required to determine numbers of viral copies in MCD.
Our double immunohistochemical analysis revealed that flat endothelial cells of atypical vessels in early KS lesions expressed both LANA and VEGFR-3. It was difficult to distinguish KS cells from non-KS endothelial cells strictly in HE-stained sections of early KS lesions. VEGFR-3 is a useful marker for KS cells [33] . Our data suggest that a large proportion of extended endothelial cells in the patch stage of KS and KS spindle cells were already infected with KSHV. Because lytic protein expression was also rare during the patch stage, KSHV infected these cells latently. Thus, KSHV infection may be established in endothelial cells at a very early stage in KS lesions. We suggest that this is one of the reasons why numbers of KSHV copies in patch-stage lesions were similar to those in nodular-stage lesions of classic KS in real-time PCR results ( figure 3) .
Computerized-image analysis has been used by several groups to count cells in immunohistochemically stained sections [35] [36] [37] . Technically, our image analysis method was much easier than previously reported ones, in that (1) image files did not need to be captured at high magnification-relatively low magnifications (ϫ40-ϫ100, not ϫ400) are preferred; (2) splitting of images to red, green, and blue and counting of cells were done automatically; (3) tracing positive and negative cells could be easily visually confirmed; (4) it took only a few minutes to analyze an image; and (5) ImageJ is freeware. The unique features of the present study involve the combination of real-time PCR and computerized-image analysis. Real-time PCR is a powerful tool for measuring numbers of viral copies quickly and easily. However, every pathologic sample contains various numbers of normal cells, and it is impossible to extract DNA strictly from lesions in pathologic samples. Therefore, when DNA is extracted from pathologic samples that contain virus-infected cells, extracted DNA will contain not only DNA from virus-infected cells but also DNA from uninfected cells. Almost all studies that use realtime PCR encounter this limitation. Immunohistochemical analysis and in situ hybridization (ISH) are useful techniques that allow the localization of virus-infected cells. However, immunohistochemical analysis and ISH are not quantitative. Indeed, signal intensity does not correlate with copy number of the molecules or nucleotides, because signal intensity in immunohistochemical analysis and ISH differs among experiments and slides and depends on the conditions of staining or hybridization, such as incubation time, washing, temperature, fixation, and buffer. By combining real-time PCR and computerized-image analysis, the determination of relatively accurate virus numbers in infected cells becomes possible. Numbers of viral copies can be measured using real-time PCR, and numbers of virus-infected cells can be estimated with computerized-image analysis. Both results are required to assess numbers of viral copies in a virus-infected cell. In the present study, we analyzed 1 or a few pictures per slide using computerized-image analysis. Examination of a whole slide would be ideal; however, it is difficult to scan a whole slide using a high-resolution objective lens, but that may be available in the near future using, for example, a virtual slide system. In conclusion, the combination of real-time PCR and computerized-image analysis provides a useful tool for the prediction of numbers of viral copies in virus-associated diseases and of numbers of copies of certain molecules in a cell.
